Cited by 142Sleep and related disordersTreatment of Major DepressionSleep and Wakefulness Research

Sleep and Antidepressant Treatment

Wichniak, Adam, Wierzbicka, Aleksandra, Jernajczyk, Wojciech·2012·Current Pharmaceutical Design

Abstract

The aim of this review was to describe the sleep anomalies in depression, the effects of antidepressants on sleep, the usefulness of antidepressants in the treatment of primary insomnia and insomnia in other psychiatric disorders. Depression is associated with abnormalities in the sleep pattern that include disturbances of sleep continuity, diminished slow-wave sleep (SWS) and altered rapid eye movement (REM) sleep parameters. Although none of the reported changes in sleep are specific to depression, many of them, for example increased REM density and reduced amount of SWS in the first sleep cycle, are used as biological markers for research on depression and in the development of antidepressant drugs. An antidepressant should reverse abnormalities in the sleep pattern. However, many antidepressants can worsen sleep. Because of the activating effects of some drugs, for example imipramine, desipramine, fluoxetine, paroxetine, venlafaxine, reboxetine and bupropion, many patients who take them have to be co-prescribed with sleep-promoting agents to improve sleep. Even in maintenance treatment with activating antidepressants as many as 30-40% of patients may still suffer from insomnia. Antidepressants with sleep-promoting effects include sedative antidepressants, for example doxepin, mirtazapine, trazodone, trimipramine, and agomelatine which promotes sleep not through a sedative action but through resynchronization of the circadian rhythm. Sedative antidepressants are frequently used in the treatment of primary insomnia, although not many double-blind studies have been provided to support such an approach to insomnia treatment. One exception is doxepin, which has been approved for the treatment of insomnia characterized by difficulties in maintaining sleep.

Integrity signals

Registry

Crossref · 10.2174/138161212803523608

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wichniak, A., Wierzbicka, A., & Jernajczyk, W.
Affiliations
Institute of Psychiatry and Neurology (PL)
Venue
Current Pharmaceutical Design
Published
2012-10-13
Volume
18
Issue
36
Pages
5802-5817
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2127360167
Cited by
142
References
168
Citations by year
2026: 15 · 2025: 11 · 2024: 14 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 16 · 2019: 10 · 2018: 6 · 2017: 12 · 2016: 9 · 2015: 12 · 2014: 8 · 2013: 5 · 2012: 2
FWCI
11.57
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Keywords
depression, sleep disorders, antidepressants, insomnia, slow-wave sleep, REM sleep, antidepressant side effects, doxepin, mirtazapine, trazodone, trimipramine, agomelatine, circadian rhythm, sleep maintenance
MeSH terms
Antidepressive Agents, Depression, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Risk Factors, Sleep, Sleep Wake Disorders, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review